Our sales agents will guide you on how to buy 100% authentic Asthma Treatments (Omalizumab) at wholesale prices. Omalizumab is a monoclonal antibody used to treat moderate to severe persistent allergic asthma and chronic idiopathic urticaria. It works by binding to immunoglobulin E (IgE), reducing allergic reactions and controlling symptoms not managed by standard treatments.
Can’t spot what you need in our catalog? Fret not–just sign up for our expert consultations. We will provide the insights you need. We're here to guide you to your clinic's potential; no product browsing needed
Omalizumab, marketed as XOLAIR®, is primarily used to treat two conditions: moderate to severe persistent allergic asthma and chronic idiopathic urticaria (CIU). It is prescribed for patients whose symptoms are not adequately controlled with standard treatments like inhaled corticosteroids for asthma and antihistamines for urticaria.
Omalizumab is indicated for the treatment of moderate to severe persistent allergic asthma and chronic idiopathic urticaria (CIU). The dosage is determined based on the patient’s body weight and baseline IgE levels for asthma, while for CIU, it is administered as a fixed dose.
Omalizumab can cause a range of side effects, from mild to severe. Common side effects include injection site reactions and upper respiratory tract infections. Serious side effects, such as anaphylaxis, though rare, are possible and require immediate medical attention.
Omalizumab is administered via subcutaneous injection. The injection may take several seconds due to the viscosity of the solution. The administration must be performed in a clinical setting where healthcare providers can manage potential anaphylaxis.
Our sales agents will guide you on how to buy 100% authentic Asthma Treatments (Omalizumab) at wholesale prices. Book a meeting today!